Headlines From "The Pink Sheet" DAILY

Hybrid Public Option? Proposal For New State Insurance Plan Passes Cmte.

Sen. Cantwell's proposal would have states negotiate payments that could be higher than Medicaid rates. Medicaid reference pricing would not be used in negotiations with manufacturers.   read more

 

Part D Low-Income Providers In 2010: Universal American, UnitedHealth Stand To Gain

CMS announces 2010 Part D plan sponsors Oct. 1, indicates which sponsors likely to gain or lose low-income members.   read more

 

Adimab's Search Results Lead to Google Ventures

Adimab CEO Gerngross wouldn't disclose the amount of Series D money raised, but promised "there will be interactions" between Adimab and parent company Google.   read more

 

Sanofi Broadens Portfolio By Licensing A Monoclonal Antibody From Merrimack

Privately held Merrimack gets $60 million upfront for MM-121, a monoclonal antibody in Phase I/II.   read more

 

Sanofi Creates Ophtho Division through Earn-Out Acquisition of Fovea

By buying its Paris-based neighbor, Sanofi-Aventis creates an ophthalmology division and a chance to license more.   read more

 

Two Oncologics Face Tough ODAC Review: Problems Of Efficacy For Schering's PegIntron And Safety For GSK's Votrient

The Oncologic Drugs Advisory Committee will meet Oct. 5 to evaluate the sNDA for PegIntron to treat melanoma and the NDA for Votrient to treat renal cell carcinoma.   read more

 

China Orders Pfizer And Wyeth To Divest Certain Operations As Condition To Merger Approval

Merger watchers were keeping close tabs on whether one-year-old Anti-Monopoly Law would be used to block deal in China; divestments include an animal vaccine business.   read more

 

The Pink Sheet" DAILY is the leading on-line news and analysis service for the pharmaceutical industry. For information about a subscription or to sign up for a free trial, click here.